Bifidobacterium longum subsp. longum
Bifidobacterium longum subsp. longum has been studied in 1 paper since 2024: none in people yet, 1 in cells. No study of it in people or animals has been published yet. The newest paper, Apr 30, 2024: “Highly conserved bifidobacteria in the human gut: Bifidobacterium longum subsp. longum as a potential modulator of elderly innate immunity”.
1 paper studies it1 findingUpdated
- 1 lab in 1 country
- Funders: Ministero della Salute and 1 more
- Cells1
What did studies of Bifidobacterium longum subsp. longum find?
1Studies of Bifidobacterium longum subsp. longum measured 1 outcome; the most studied are inflammation (1 study).
Inflammation
downin human cells1
1 study
Inflammation
downin human cells1
Bifidobacterium longum subsp. longum decreases inflammation in human cells.
“revealing differences in the host immune system transcriptome, with a reduction in gene expression of inflammation-related cytokines.”
Cellsin vitro microbe-host interactions
Beneficial microbes